Legal abortion. Termination of pregnancy, affecting fetus and newborn
Conditions
Interventions
Intervention 1: In the intervention group, patients receive a single oral dose of 20 mg Letrozole, produced by Abureyhan Pharmaceutical Company. Additionally, misoprostol is administered as an adjunct
Sponsors
Sanandaj University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Age over 18 years Gestational age less than 18 weeks confirmed by ultrasound on the first day of the study Candidates for legal and medical abortion Hemoglobin level more than 10 g/L
Exclusion criteria
Exclusion criteria: Patients with severe bleeding requiring emergency curettage Any known allergy to Misoprostol and Letrozole
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Miscarriage duration. Timepoint: Time points for measuring the rate of miscarriage: Measuring the rate of excretion of pregnancy products at the beginning of the study (24 hours after the start of the intervention) and 4, 8, 12, and 24 hours after the start of misoprostol and letrozole. Method of measurement: the time it takes for the remnants of the pregnancy to start coming out in hours.;Type of abortion (complete, incomplete). Timepoint: Time points for measuring the rate of abortion: Measuring the rate of excretion of pregnancy products at the beginning of the study (24 hours after the start of the intervention) and 4, 8, 12, and 24 hours after the start of misoprostol and letrozole. Method of measurement: observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Zeinab Hemmati
Sanandaj University of Medical Sciences
Outcome results
None listed